Jonathan Watanabe, PharmD, MS, PhD, BCGP, discussed gaps within primary care in the context of the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.
GLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.
Kathryn Litten, PharmD, discussed the pharmacist’s role in helping patients manage metabolic dysfunction-associated steatotic liver disease.
A deep dive for pharmacists into this frequently debilitating disorder
Understanding post-PREP implications is critical for evaluating current public health delivery, identifying ongoing access, and informing future policy.
Matthew Zirwas, MD, shares his step-by-step pearls for quelling the pruritic skin condition.
The drug’s approval was based on the results of 3 clinical trials.
Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.
Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
As concerns mount over potential shifts in vaccine recommendations, Deanna Tran, PharmD, BCACP, FAPhA, advocates for rigorous data assessment and patient-centered communication strategies.
Explore effective strategies for managing menstrual pain, including diet, exercise, and nonpharmacological therapies, while embracing women's health awareness.
A conversation with Scott Biggs and Greg Mitchell at the American Associated Pharmacies 2025 Annual Conference.
Following his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter caught up with Drug Topics to discuss the pharmacists’ role in diabetes management.
Brooklyn Morgan, PharmD, discusses the transformation of pharmacy practice from a regulatory model to a more flexible approach.
Researchers used an online English-language survey questionnaire to collect data on pharmacists from Germany and Switzerland about how their knowledge and dispensing frequency of biologics and biosimilars changed from before and after the pandemic.
Often referred to as “long COVID” patients or “long-haulers,” these patients continue to experience symptoms of illness far past the acute phase of this viral disease.
A perspective on the CMS Innovation Center roundtable on health equity.
As respiratory viruses and COVID-19 variants lurk seemingly everywhere, here’s how best to detect and differentiate.
Protection from the harsh rays of the sun is crucial for everyone—including children. Now that summer has arrived, a refresher course can go a long way in preventing skin damage and disorders due to the sun.
Zavegepant joins other CGRP antagonists as an option for individuals experiencing migraine.
Henry Ukachukwu Michael, PhD, discusses the importance of optimizing medication utilization in patients with long COVID.
An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.
Todd Mizeski, Esq, a Partner in Frier Levitt’s Life Sciences, Litigation Department, discusses the case of Rutledge v. Pharmaceutical Care Management Association.
In this article, we will review the evidence describing a possible link between vitamin D and COVID-19.
A panelist discusses how point-of-care testing can increase pharmacy revenue through the tests themselves and related OTC product recommendations, and by attracting new patients who were not previously customers.
There is a bias in this country against people whose medical condition is perceived to be the result of their own lifestyle choices. To combat stigma and its harmful effects, there needs to be broader understanding—even among medical professionals.
The research points to the importance of isolating offending organism.
Sarah Thomas and David Skomo of HealthDyne discuss some of the most useful innovations that have been helpful for pharmacies.